NASDAQ:WHRT - WorldHeart Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
Average VolumeN/A
Market Capitalization$7.70 million
P/E RatioN/A
Dividend YieldN/A

About WorldHeart (NASDAQ:WHRT)

World Heart Corporation (WorldHeart) is engaged in the development and sale of ventricular assist devices (VADs), particularly the Levacor Rotary VAD (Levacor VAD or Levacor). VADs are mechanical assist devices that supplement the circulatory function of the heart by re-routing blood flow through a mechanical pump allowing for the restoration of normal blood circulation. VADs are used for treatment of patients with severe heart failure, including patients whose hearts are irreversibly damaged and cannot be treated effectively by medical or surgical means other than transplant. Bridge-to-Transplant therapy (BTT) therapy involves implanting a VAD in a transplant-eligible patient to maintain or improve the patient's health until a donor heart becomes available. In August 2012, HeartWare International, Inc. acquired WorldHeart.

Receive WHRT News and Ratings via Email

Sign-up to receive the latest news and ratings for WHRT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A


Outstanding SharesN/A

WorldHeart (NASDAQ:WHRT) Frequently Asked Questions

What is WorldHeart's stock symbol?

WorldHeart trades on the NASDAQ under the ticker symbol "WHRT."

Who are WorldHeart's key executives?

WorldHeart's management team includes the folowing people:
  • Michael Sumner Estes Ph.D., Independent Chairman of the Board (Age 69)
  • Morgan R. Brown CPA, Interim Principal Executive Officer, Chief Financial Officer, Executive Vice President, Secretary (Age 47)
  • John Campbell Woodard Ph.D., Senior Vice President - Scientific Affairs (Age 56)
  • Jeani C. Delagardelle, Independent Director
  • William C. Garriock, Independent Director (Age 74)
  • Anders D. Hove M.D., Independent Director (Age 50)
  • Eugene B. Jones, Independent Director (Age 64)
  • Austin W. Marxe, Independent Director (Age 71)

Has WorldHeart been receiving favorable news coverage?

Media headlines about WHRT stock have trended somewhat positive this week, Accern reports. The research group identifies negative and positive media coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. WorldHeart earned a news impact score of 0.21 on Accern's scale. They also gave news stories about the healthcare company an impact score of 47.67 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the immediate future.

How do I buy shares of WorldHeart?

Shares of WHRT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How big of a company is WorldHeart?

WorldHeart has a market capitalization of $7.70 million.

How can I contact WorldHeart?

WorldHeart's mailing address is 500 Old Connecticut Path, Ma, SALT LAKE CITY, UT 01701, United States. The healthcare company can be reached via phone at +1-508-7390864.

MarketBeat Community Rating for WorldHeart (WHRT)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  21 (Vote Outperform)
Underperform Votes:  26 (Vote Underperform)
Total Votes:  47
MarketBeat's community ratings are surveys of what our community members think about WorldHeart and other stocks. Vote "Outperform" if you believe WHRT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WHRT will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

WorldHeart (NASDAQ:WHRT) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
(Data available from 5/24/2016 forward)


WorldHeart (NASDAQ:WHRT) Earnings History and Estimates Chart

Earnings by Quarter for WorldHeart (NASDAQ:WHRT)

WorldHeart (NASDAQ WHRT) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/9/2012Q1 2012($0.10)ViewN/AView Earnings Details
3/30/2012Q4 2011$0.03ViewN/AView Earnings Details
11/10/2011Q3 2011($0.11)($0.09)ViewN/AView Earnings Details
8/10/2011Q2 2011($0.13)ViewN/AView Earnings Details
5/13/2011Q1 2011($0.12)($0.16)ViewN/AView Earnings Details
5/17/2010Q1 2010($0.32)($0.24)ViewN/AView Earnings Details
3/1/2010Q4 2009($0.31)($0.35)ViewN/AView Earnings Details
3/27/2008Q4 2007($19.82)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


WorldHeart (NASDAQ:WHRT) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

WorldHeart (NASDAQ WHRT) Insider Trading and Institutional Ownership History

Insider Trading History for WorldHeart (NASDAQ:WHRT)

WorldHeart (NASDAQ WHRT) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
(Data available from 1/1/2013 forward)


WorldHeart (NASDAQ WHRT) News Headlines

No headlines for this company have been tracked by

SEC Filings

WorldHeart (NASDAQ:WHRT) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


WorldHeart (NASDAQ:WHRT) Income Statement, Balance Sheet and Cash Flow Statement


WorldHeart (NASDAQ WHRT) Stock Chart for Thursday, May, 24, 2018

Loading chart…

This page was last updated on 5/24/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.